A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion. (13th October 2015)
- Record Type:
- Journal Article
- Title:
- A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion. (13th October 2015)
- Main Title:
- A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion
- Authors:
- Boero, Martina
Pagliaro, Pasquale
Tullio, Francesca
Pellegrino, Rosa M.
Palmieri, Antonietta
Ferbo, Ludovica
Saglio, Giuseppe
De Gobbi, Marco
Penna, Claudia
Roetto, Antonella - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <p>Transferrin receptor 2 (Tfr2) is an iron‐modulator transcribed in two isoforms, Tfr2α and Tfr2β. The latter is expressed in the heart. We obtained two mouse models with silencing of Tfr2β: one with a normal systemic iron amount (SIA), <italic>i.e., </italic> Tfr2‐KI, and the other, <italic>i.e., </italic> LCKO‐KI, with high SIA due to hepatic Tfr2α silencing. We aimed to assess whether Tfr2β might play a role in myocardial injury and whether Tfr2β silencing might modify proteins of iron metabolism, antioxidant, apoptotic, and survival enzyme activities in the heart undergoing ischemia/reperfusion (I/R).</p> <p>Isolated hearts of wild‐type (WT) and Tfr2‐null mice were studied before or after an I/R protocol, and proteins/RNA analyzed by Western blot and/or quantitative PCR.</p> <p>Tfr2β increased in WT hearts subject to I/R, and both Tfr2β null mice hearts were protected against I/R injury (about 40% smaller infarct‐size compared to WT hearts). RISK kinases (ERK1/2‐AKT‐PKCε) were found up‐regulated after I/R in Tfr2‐KI, whereas SAFE enzyme (Stat3) and GSK3β resulted phosphorylated during I/R in LCKO‐KI hearts. While HO‐1 and HIF‐2a were high in both Tfr2β‐null mice, Catalase, and proapoptotic factors were upregulated only in LCKO‐KI. Finally, Tfr2‐KI hearts presented an increased Ferritin‐H and a decreased Ferroportin1, whereas LCKO‐KI hearts displayed an upregulation of Ferritin‐L chain and DMT1/Hamp‐RNA.</p> <p>In<abstract abstract-type="main"> <title>Abstract</title> <p>Transferrin receptor 2 (Tfr2) is an iron‐modulator transcribed in two isoforms, Tfr2α and Tfr2β. The latter is expressed in the heart. We obtained two mouse models with silencing of Tfr2β: one with a normal systemic iron amount (SIA), <italic>i.e., </italic> Tfr2‐KI, and the other, <italic>i.e., </italic> LCKO‐KI, with high SIA due to hepatic Tfr2α silencing. We aimed to assess whether Tfr2β might play a role in myocardial injury and whether Tfr2β silencing might modify proteins of iron metabolism, antioxidant, apoptotic, and survival enzyme activities in the heart undergoing ischemia/reperfusion (I/R).</p> <p>Isolated hearts of wild‐type (WT) and Tfr2‐null mice were studied before or after an I/R protocol, and proteins/RNA analyzed by Western blot and/or quantitative PCR.</p> <p>Tfr2β increased in WT hearts subject to I/R, and both Tfr2β null mice hearts were protected against I/R injury (about 40% smaller infarct‐size compared to WT hearts). RISK kinases (ERK1/2‐AKT‐PKCε) were found up‐regulated after I/R in Tfr2‐KI, whereas SAFE enzyme (Stat3) and GSK3β resulted phosphorylated during I/R in LCKO‐KI hearts. While HO‐1 and HIF‐2a were high in both Tfr2β‐null mice, Catalase, and proapoptotic factors were upregulated only in LCKO‐KI. Finally, Tfr2‐KI hearts presented an increased Ferritin‐H and a decreased Ferroportin1, whereas LCKO‐KI hearts displayed an upregulation of Ferritin‐L chain and DMT1/Hamp‐RNA.</p> <p>In conclusion, Tfr2β isoform is involved in cardiac iron metabolism and its silencing leads to a protected phenotype (antioxidants, RISK, and/or SAFE upregulation) against I/R challenging. Iron‐dependent signals involved in cardioprotection seem to be positively affected by Tfr2β downregulation and subsequent Ferritins upregulation. © 2015 BioFactors, 41(5):360–371, 2015</p> </abstract> … (more)
- Is Part Of:
- BioFactors. Volume 41:Number 5(2015:Sep./Oct.)
- Journal:
- BioFactors
- Issue:
- Volume 41:Number 5(2015:Sep./Oct.)
- Issue Display:
- Volume 41, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 41
- Issue:
- 5
- Issue Sort Value:
- 2015-0041-0005-0000
- Page Start:
- 360
- Page End:
- 371
- Publication Date:
- 2015-10-13
- Subjects:
- Vitamins -- Physiological effect -- Periodicals
Trace elements -- Physiological effect -- Periodicals
Growth factors -- Physiological effect -- Periodicals
Plant growth promoting substances -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Nutritional Physiological Phenomena -- Periodicals
Trace Elements -- metabolism -- Periodicals
Vitamins -- metabolism -- Periodicals
Molecular Biology -- Periodicals
612.399 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1872-8081 ↗
http://search.epnet.com/direct.asp?jid=BFT&db=afh ↗
http://www.ebscohost.com ↗
http://www3.interscience.wiley.com/journal/121452383/ ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0951-6433;screen=info;ECOIP ↗ - DOI:
- 10.1002/biof.1237 ↗
- Languages:
- English
- ISSNs:
- 0951-6433
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2072.123000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3540.xml